A NOVEL STRATEGY FOR ORGAN ALLOGRAFTS USING SUBLETHAL (7 Gy) IRRADIATION FOLLOWED BY INJECTION OF DONOR BONE MARROW CELLS VIA PORTAL VEIN1
Authors:
- Junko TokiJTJunko Toki
- Muneo InabaMIMuneo Inaba
- Kikuya SugiuraKSKikuya Sugiura
- Tianxue FanTFTianxue Fan
- Chengze YuCYChengze Yu
- Zhexiong LianZLZhexiong Lian
- Katsunori TakaseKTKatsunori Takase
- Biao FengBFBiao Feng
- Tomoki ItoTITomoki Ito
- Yunze CuiYCYunze Cui
- Guoxiang YangGYGuoxiang Yang
- 1 June 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 71 (12) , 1725-1731
Abstract
A new strategy for organ allografts that does not require recourse to immunosuppressants is established in mice. The strategy includes sublethal (7 Gy) irradiation followed by the injection of donor bone marrow cells (BMCs) via the portal vein (P.V.) and organ allografts 1 day after irradiation. Irradiation doses (≤7 Gy) are found to allow the recipients to survive without the need to reconstitute the BMCs, as the recipient hematolymphoid cells can gradually recover. One hundred percent of recipients irradiated with 7 Gy followed by either P.V. or i.v. injection of donor BMCs accept organ allografts (the skin, pancreas, and adrenal glands) for more than 1 year. However, organ allograft survival rates decrease when irradiation doses are reduced; the skin graft survival rate of mice treated with 6.5 Gy and P.V. injection of BMCs is 79%, whereas that of mice treated with 6.5 Gy and i.v. injection is 50%, indicating that the P.V. injection of BMCs induces persistent tolerance more effectively than the i.v. injection. H-2 typing reveals that almost all the hematolymphoid cells (>98%) in the peripheral blood and hematolymphoid organs are donor-derived even 1 year after the treatment (7 Gy and P.V.). The T cells are tolerant to both donor-type and host-type MHC determinants. The major mechanism underlying the persistent tolerance induced by this strategy seems to be because of clonal deletion. This simple and safe strategy would be of great advantage for human organ transplantation.Keywords
This publication has 44 references indexed in Scilit:
- Bone Marrow NK1.1− and NK1.1+ T Cells Reciprocally Regulate Acute Graft versus Host DiseaseJournal of Experimental Medicine, 1999
- Regulation of IFN-γ and IL-10 synthesis in vivo, as well as continuous antigen exposure, is associated with tolerance to murine skin allograftsCellular Immunology, 1995
- Fate of allogeneic or syngeneic cells in intravenous or portal vein injection: Possible explanation for the mechanism of tolerance induction by portal vein injectionEuropean Journal of Immunology, 1994
- TRANSPLANTATION TOLERANCE INDUCED BY CTLA4-Ig1Transplantation, 1994
- Bone marrow transplantation as a strategy for treatment of non-insulin-dependent diabetes mellitus in KK-Ay mice.Journal of Experimental Medicine, 1992
- Immunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation MoleculeScience, 1992
- Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lgScience, 1992
- T cell tolerance by clonal elimination in the thymusCell, 1987
- Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance.Journal of Experimental Medicine, 1985
- On the thymus in the differentiation of "H-2 self-recognition" by T cells: evidence for dual recognition?Journal of Experimental Medicine, 1978